Armed Forces Institute of Regenerative Medicine Annual Report 2010
Abstract
The AFIRM's success to date can be ascribed at least in part to the program's emphasis on establishing partnerships and collaborations. The AFIRM is a six-way partnership among the U.S. Army, Navy, and Air Force, the Veterans Health Administration, the Defense Health Program, and the National Institutes of Health. The AFIRM is composed of two independent research consortia working with the U.S. Army Institute of Surgical Research and the Major Extremity Trauma Research Consortium (METRC). One research consortium is led by Wake Forest University Baptist Medical Center and the McGowan Institute for Regenerative Medicine in Pittsburgh (WFPC [Wake Forest-Pittsburgh Consortium]) while the other is led by Rutgers, the State University of New Jersey, and the Cleveland Clinic (RCCC [Rutgers- Cleveland Clinic Consortium]). Each research consortium contains approximately 15 member organizations, which are mostly academic institutions. Notably, AFIRM member organizations have established collaborations/ partnerships with over 50 academic or industrial institutions, located both within and outside of the United States (including Australia, China, Finland, Germany, and the Netherlands).
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2011
- Accession Number
- ADA536112
Entities
People
- Terry Irgens
Organizations
- United States Army Medical Research and Development Command